The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Bridge Medicines announced an agreement with Weill Cornell Medicine to develop a novel sphingosine 1-phosphate (S1P) receptor modulator.
read more
AstraZeneca Pharmaceuticals
The FDA has granted ODD for saracatinib, a potential new medicine for the treatment of idiopathic pulmonary fibrosis, a type of lung disease that ...
read more
Neurogene has enrolled the first patient in a natural history study of aspartylglucosaminuria (AGU), a rare neurodegenerative lysosomal storage ...
read more
Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche to commercialize its chemical synthesis ...
read more
Sartorius Stedim Biotech is introducing its new generation of ambr® 15 cell culture automated microbioreactor system.
read more
The FDA plays an important role in helping to address the high cost of medicines through the development of generic drugs, biosimilars, and ...
read more
The MDA announced the awarding of 26 new grants totaling more than $7.5 million toward research focused on a variety of rare neuromuscular diseases (...
read more
BioTheryX announced the FDA has cleared the company’s IND for BTX-A51, an oral multi-kinase inhibitor, for the treatment of patients with relapsed/...
read more
Rejenevie™ Therapeutics announced the commencement of the company's Phase II clinical trial to study the safety and effectiveness of its proprietary ...
read more
The FDA Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals in requesting access to unapproved ...
read more
The Lung Cancer Research Foundation (LCRF) announced the awardees of the 2019 LCRF Research Grant on Disparities in Lung Cancer.
read more
Geneos announced the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology.
read more
Pharmazz has received permission to initiate a study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke...
read more
GEMoaB GmbH announced the dosing of the first patient in a Phase I open-label, dose escalation study of GEM3PSCA, an Affinity-Tailored Adapter for T-...
read more
The DSMB recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114 in what is being ...
read more